Swiss Lions 100 | 2026 edition
Medacta
Medacta is No. 100 in the Swiss Lions 100 and No. 14 in Life Sciences & Health, with a score of 28.2 out of 100. Headquarters: Castel San Pietro, canton of Ticino.
- Swiss Lions score
- 28.2
- Overall rank
- 100of 100
- Life Sciences & Health
- 14of 14
About
Orthopaedic medical device company in Castel San Pietro, canton of Ticino, making hip, knee, shoulder and spine implants.
How the score is made
Global scale
CHF 614m revenue.
Swiss value
Swiss made: Partly.
Prominence
Online attention across languages, and worldwide search interest.
Impact
No current SBTi target. Not a certified B Corp.
Philanthropy
Corporate foundation: Fondazione Medacta for Life.
Key figures
- Revenue used in the ranking
- CHF 614mTTM Oct 2026, company
- Revenue
- EUR 708mTwelve months to 30 June 2026
- Net profit
- EUR 77mAttributable to shareholders
- Dividends paid
- EUR 24mTo all shareholders
- Employees worldwide
- 2,273
Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.
Profile
- Headquarters
- Castel San PietroCanton of Ticino
- Language region
- Italian-speaking
- Category
- Life Sciences & Health
- Ownership
- Listed
- Main customers
- Businesses (B2B)
- Chief executive
- Francesco SiccardiSince 2018. Source
- Founded
- 1999
Nearby in the Swiss Lions 100
Also in Life Sciences & Health
1RocheScore 80.8
2NovartisScore 78.6
3LonzaScore 59.5
4SonovaScore 54.8
5SandozScore 54.5
6StraumannScore 53.5
See all 14 brands in Life Sciences & Health.
Sources
- Revenue used in the ranking: stockanalysis.com MOVE (TTM Oct 2026).
- Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
- Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.
Something out of date?
If a figure is wrong, or Medacta can publish figures for the next edition, tell us. Corrections are recorded with their source.